Related Experiment Video
Updated: Aug 16, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
A review of hypertension management in Canada
1London Health Sciences Centre, London, Ontario. Seadna.Ledger@lhsc.on.ca
Insights
Managing cardiovascular (CV) risk involves more than medication, emphasizing lifestyle changes like diet and exercise. New hypertension guidelines suggest specific medications and caution against others for initial monotherapy, stressing frequent follow-ups.
Area of Science:
- Cardiology
- Hypertension Management
- Preventive Medicine
Background:
- Global cardiovascular (CV) risk reduction necessitates a comprehensive, multifactorial strategy.
- Lifestyle modifications, including diet and exercise, are crucial components of patient therapy alongside medication.
Purpose of the Study:
- To summarize recent recommendations for managing hypertension based on large clinical trials.
- To provide guidance on initial pharmacotherapy choices and contraindications for hypertensive patients.
- To emphasize the importance of frequent follow-up and treatment adjustments for achieving target blood pressures.
Main Methods:
- Review of findings from major hypertension trials.
- Analysis of current guidelines for antihypertensive medication.
- Evaluation of treatment strategies for diverse patient populations.
Main Results:
- Statins are recommended for hypertensive patients irrespective of cholesterol levels.
- Aspirin (ASA) is advised for patients with well-controlled hypertension.
- Thiazide diuretics and Angiotensin II Receptor Blockers (ARBs) are suitable initial treatment options.
- Beta-blockers in the elderly, ACE inhibitors in Black patients, and alpha-adrenergic blockers are not recommended as initial monotherapy.
Conclusions:
- A multifactorial approach, integrating medication and lifestyle changes, is essential for reducing CV risk.
- Specific medication choices and avoidance of certain agents as initial monotherapy are critical in hypertension management.
- Regular patient follow-up and tailored therapeutic adjustments are necessary to achieve optimal blood pressure control.
Abstract:
Reducing a patient's global CV risk requires a multifactorial approach. Medication is only a part of a patient's therapy. Lifestyle modifications such as diet and exercise should be encouraged. Several larger trials in hypertension have provided us with new recommendations: Statins for hypertensive patients regardless of cholesterol. ASA in patients with well-controlled hypertension. Thiazide diuretics and ARBs can be initial treatment options. Avoid the following as initial monotherapy in hypertensive patients: beta-blockers in the elderly, ACE inhibitors in black patients and alpha-adrenergic blockers. Follow-up of these largely asymptomatic patients should be performed frequently. Reasons for poor response should be investigated and additional antihypertensive therapy added, if appropriate, to achieve target blood pressures.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction